Silverberg Bernstein Capital Management LLC Increases Position in Cognyte Software Ltd. (NASDAQ:CGNT)

Silverberg Bernstein Capital Management LLC lifted its position in Cognyte Software Ltd. (NASDAQ:CGNTFree Report) by 2.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 100,300 shares of the medical device company’s stock after purchasing an additional 2,000 shares during the period. Silverberg Bernstein Capital Management LLC’s holdings in Cognyte Software were worth $681,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of CGNT. G2 Investment Partners Management LLC increased its stake in shares of Cognyte Software by 241.5% in the fourth quarter. G2 Investment Partners Management LLC now owns 1,366,163 shares of the medical device company’s stock worth $8,784,000 after purchasing an additional 966,163 shares in the last quarter. Acadian Asset Management LLC increased its stake in shares of Cognyte Software by 30.3% in the first quarter. Acadian Asset Management LLC now owns 2,304,970 shares of the medical device company’s stock worth $19,041,000 after purchasing an additional 536,393 shares in the last quarter. Scalar Gauge Management LLC purchased a new stake in shares of Cognyte Software in the fourth quarter worth $2,001,000. Perigon Wealth Management LLC purchased a new stake in shares of Cognyte Software in the first quarter worth $811,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd purchased a new stake in shares of Cognyte Software in the second quarter worth $586,000. 72.92% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of brokerages have recently issued reports on CGNT. StockNews.com cut shares of Cognyte Software from a “strong-buy” rating to a “buy” rating in a research note on Tuesday. Wedbush raised their target price on shares of Cognyte Software from $8.00 to $9.00 and gave the company a “neutral” rating in a research note on Thursday, June 20th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Cognyte Software in a research note on Tuesday, September 10th.

Check Out Our Latest Stock Report on Cognyte Software

Cognyte Software Trading Up 3.1 %

CGNT traded up $0.20 during trading on Friday, hitting $6.67. 305,034 shares of the company traded hands, compared to its average volume of 322,420. The company has a market cap of $473.72 million, a PE ratio of -39.24 and a beta of 1.73. The stock’s 50-day simple moving average is $7.12 and its two-hundred day simple moving average is $7.40. Cognyte Software Ltd. has a 1 year low of $4.00 and a 1 year high of $8.70.

Cognyte Software (NASDAQ:CGNTGet Free Report) last issued its quarterly earnings data on Tuesday, September 10th. The medical device company reported $0.05 EPS for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.07. Cognyte Software had a negative net margin of 1.35% and a negative return on equity of 2.56%. The business had revenue of $84.40 million during the quarter, compared to analysts’ expectations of $83.69 million. During the same period last year, the company posted ($0.11) EPS. The business’s revenue was up 9.5% on a year-over-year basis. Equities analysts expect that Cognyte Software Ltd. will post -0.31 EPS for the current year.

Insiders Place Their Bets

In other Cognyte Software news, insider Topline Capital Management, Ll acquired 416,040 shares of the company’s stock in a transaction on Thursday, September 12th. The stock was acquired at an average cost of $6.30 per share, with a total value of $2,621,052.00. Following the purchase, the insider now directly owns 9,020,184 shares of the company’s stock, valued at approximately $56,827,159.20. This represents a 0.00 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, major shareholder Topline Capital Partners, Lp bought 553,591 shares of the stock in a transaction dated Wednesday, September 11th. The stock was purchased at an average price of $6.31 per share, for a total transaction of $3,493,159.21. Following the acquisition, the insider now owns 8,604,144 shares of the company’s stock, valued at $54,292,148.64. The trade was a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Topline Capital Management, Ll bought 416,040 shares of the stock in a transaction dated Thursday, September 12th. The stock was purchased at an average price of $6.30 per share, with a total value of $2,621,052.00. Following the acquisition, the insider now directly owns 9,020,184 shares in the company, valued at approximately $56,827,159.20. The trade was a 0.00 % increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 62.70% of the company’s stock.

Cognyte Software Profile

(Free Report)

Cognyte Software Ltd. provides an investigative analytics software to governments and enterprises worldwide. Its Actionable Intelligence for a Safer World, an open software designed to help governments and enterprises accelerate and enhance the effectiveness of investigations. The company offers network intelligence analytics, threat intelligence analytics, decision intelligence analytics, and operational intelligence analytics solutions.

Featured Stories

Want to see what other hedge funds are holding CGNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognyte Software Ltd. (NASDAQ:CGNTFree Report).

Institutional Ownership by Quarter for Cognyte Software (NASDAQ:CGNT)

Receive News & Ratings for Cognyte Software Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognyte Software and related companies with MarketBeat.com's FREE daily email newsletter.